120 related articles for article (PubMed ID: 20075437)
21. Decreased parathyroid Klotho expression is associated with persistent hyperparathyroidism after kidney transplantation.
Hong YA; Choi DE; Lim SW; Yang CW; Chang YK
Transplant Proc; 2013 Oct; 45(8):2957-62. PubMed ID: 24157012
[TBL] [Abstract][Full Text] [Related]
22. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
[TBL] [Abstract][Full Text] [Related]
23. Calcium-sensing receptor and apoptosis in parathyroid hyperplasia of patients with secondary hyperparathyroidism.
Lee HJ; Seo UH; Kim WY; Woo SU; Lee JB
J Int Med Res; 2013 Feb; 41(1):97-105. PubMed ID: 23569134
[TBL] [Abstract][Full Text] [Related]
24. Proliferation of parathyroid cells negatively correlates with expression of parathyroid hormone-related protein in secondary parathyroid hyperplasia.
Matsushita H; Hara M; Endo Y; Shishiba Y; Hara S; Ubara Y; Nakazawa H; Suzuki N; Kawaminami K; Kido T; Li Q; Grimelius L
Kidney Int; 1999 Jan; 55(1):130-8. PubMed ID: 9893121
[TBL] [Abstract][Full Text] [Related]
25. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor].
Tokumoto M; Taniguchi M; Matsuo D; Tsuruya K; Hirakata H; Iida M
Clin Calcium; 2005 Sep; 15 Suppl 1():206-16. PubMed ID: 16279026
[No Abstract] [Full Text] [Related]
26. Co-expression of parathyroid hormone and chromogranin A in secondary hyperparathyroidism: a functional marker for secretory activity of hyperplastic nodules.
Tanaka R; Umemura S; Kakuta T; Fujisaki T; Sakai H; Saitoh A; Osamura RY
Pathol Res Pract; 2003; 199(2):93-9. PubMed ID: 12747471
[TBL] [Abstract][Full Text] [Related]
27. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism.
Yano S; Sugimoto T; Tsukamoto T; Chihara K; Kobayashi A; Kitazawa S; Maeda S; Kitazawa R
Kidney Int; 2000 Nov; 58(5):1980-6. PubMed ID: 11044218
[TBL] [Abstract][Full Text] [Related]
28. Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia.
Fan Y; Liu W; Bi R; Densmore MJ; Sato T; Mannstadt M; Yuan Q; Zhou X; Olauson H; Larsson TE; Toka HR; Pollak MR; Brown EM; Lanske B
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3749-E3758. PubMed ID: 29618612
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism.
Välimäki S; Farnebo F; Forsberg L; Larsson C; Farnebo LO
Kidney Int; 2001 Nov; 60(5):1666-75. PubMed ID: 11703583
[TBL] [Abstract][Full Text] [Related]
30. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
Koizumi M; Komaba H; Fukagawa M
Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
[TBL] [Abstract][Full Text] [Related]
31. Reduced binding of [3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure.
Korkor AB
N Engl J Med; 1987 Jun; 316(25):1573-7. PubMed ID: 3035373
[TBL] [Abstract][Full Text] [Related]
32. Relationship between parathyroid mass and parathyroid hormone level in hemodialysis patients with secondary hyperparathyroidism.
Fang L; Tang B; Hou D; Meng M; Xiong M; Yang J
BMC Nephrol; 2015 Jun; 16():82. PubMed ID: 26058796
[TBL] [Abstract][Full Text] [Related]
33. Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism.
Carling T; Rastad J; Szabó E; Westin G; Akerström G
J Clin Endocrinol Metab; 2000 May; 85(5):2000-3. PubMed ID: 10843188
[TBL] [Abstract][Full Text] [Related]
34. Localization of hyperfunctioning parathyroid glands by selective venous sampling in reoperation for primary or secondary hyperparathyroidism.
Reidel MA; Schilling T; Graf S; Hinz U; Nawroth P; Büchler MW; Weber T
Surgery; 2006 Dec; 140(6):907-13; discussion 913. PubMed ID: 17188137
[TBL] [Abstract][Full Text] [Related]
35. Activator protein 2alpha mediates parathyroid TGF-alpha self-induction in secondary hyperparathyroidism.
Arcidiacono MV; Cozzolino M; Spiegel N; Tokumoto M; Yang J; Lu Y; Sato T; Lomonte C; Basile C; Slatopolsky E; Dusso AS
J Am Soc Nephrol; 2008 Oct; 19(10):1919-28. PubMed ID: 18579641
[TBL] [Abstract][Full Text] [Related]
36. Sonography for early diagnosis of enlarged parathyroid glands in patients with secondary hyperparathyroidism.
Takebayashi S; Matsui K; Onohara Y; Hidai H
AJR Am J Roentgenol; 1987 May; 148(5):911-4. PubMed ID: 3554924
[TBL] [Abstract][Full Text] [Related]
37. De novo expression of transforming growth factor-alpha in parathyroid gland tissue of patients with primary or secondary uraemic hyperparathyroidism.
Gogusev J; Duchambon P; Stoermann-Chopard C; Giovannini M; Sarfati E; Drüeke TB
Nephrol Dial Transplant; 1996 Nov; 11(11):2155-62. PubMed ID: 8941573
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D metabolism in renal disease. Sir Michael Perrin Lecture 1991.
Ritz E
J R Coll Physicians Lond; 1992 Oct; 26(4):394-9. PubMed ID: 1432883
[No Abstract] [Full Text] [Related]
39. [Pathophysiology of secondary hyperparathyroidism: the role of FGF23 and Klotho].
Mazzaferro S; Pasquali M; Tartaglione L; Rotondi S; Pirrò G
G Ital Nefrol; 2009; 26 Suppl 49():S11-7. PubMed ID: 19941273
[TBL] [Abstract][Full Text] [Related]
40. The oxyphil cell in abnormal parathyroid glands. A study of 114 cases.
Allen TB; Thorburn KM
Arch Pathol Lab Med; 1981 Aug; 105(8):421-7. PubMed ID: 6894851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]